CAGE Bio Announces Positive Topline Results From its Double-Blind Phase 2 Study Evaluating an Ionic Liquid formulation of 1% Tofacitinib In Patients with Atopic Dermatitis

MBC Biolabs2023-09-01T11:31:39-07:00August 3rd, 2023|Startup News|

This Startup Just Raised $26 Million To Develop Safer Gene Editing Tools

MBC Biolabs2023-09-01T11:34:12-07:00August 3rd, 2023|Startup News|

August 2023

MBC Biolabs2024-10-04T16:05:45-07:00August 2nd, 2023|Newsletters 2023|

UCSF researchers’ startup aims to stop allergies — starting with babies’ guts

MBC Biolabs2023-09-01T11:51:47-07:00August 1st, 2023|Startup News|

Eisai Innovation, Inc. Golden Ticket 2023

MBC Biolabs2023-09-18T09:26:19-07:00July 24th, 2023|Eisai Golden Ticket, 2023|

June 2023

MBC Biolabs2024-10-04T16:11:54-07:00June 7th, 2023|Newsletters 2023|

Nitto Golden Ticket 2023 Winner

MBC Biolabs2023-10-30T17:27:37-07:00June 2nd, 2023|Winner, 2023, Nitto Golden Ticket|

May 2023

MBC Biolabs2024-10-04T16:15:56-07:00May 3rd, 2023|Newsletters 2023|

April 2023

MBC Biolabs2024-10-04T16:19:57-07:00April 11th, 2023|Newsletters 2023|

ONO Golden Ticket 2023

MBC Biolabs2023-08-07T15:53:10-07:00April 6th, 2023|ONO Golden Ticket, 2023|